A PERSONALIZED APPROACH TO ADJUVANT CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER AFTER RADICAL SURGICAL TREATMENT BASED ON MOLECULAR MARKERS OF CHEMOSENSITIVITY
Despite advances in the treatment of non-small cell lung cancer (NSC LC), prognosis of advanced lung cancer is extremely poor. The search for additional treatment options to prevent local recurrence and distant metastases is of great importance. Monoresistance genes, such as ABCC5, BRCA1, RRM1, ERCC...
Main Authors: | L. A. Efteev, E. O. Rodionov, S. V. Miller, S. A. Tuzikov, M. M. Tsyganov, I. V. Deryusheva, N. V. Litvyakov, I. G. Frolova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2019-11-01
|
Series: | Sibirskij Onkologičeskij Žurnal |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/1196 |
Similar Items
-
PERSONALIZED APROACH TO POSTOPERATIVE CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF NON-SMALL CELL LUNG CANCER (CLINICAL CASE)
by: E. O. Rodionov, et al.
Published: (2016-07-01) -
mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer
by: M. M. Tsyganov, et al.
Published: (2019-02-01) -
Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01) -
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy Following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis
by: Wojciech Krajewski, et al.
Published: (2021-02-01) -
EXSPRESSION OF MDR-GENES AND MONORESISTANCE GENES IN NON-SMALL-CELL LUNG CANCER
by: E. L. Yumov, et al.
Published: (2016-02-01)